USOR 21270 - Ph2 ZN-c3 Tumor DNA Repair CCGA

A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in Subjects with High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Disease Types: Fallopian Tube, Gynecological/Ovarian, Peritoneal Cancer

Available at: Arlington Heights, Niles